Search
SOLACI Congress
HomeFile

File

View Category
Structural heart disease

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR

When it comes to intermediate coronary lesion revascularization decision making, functional assessment is the recommended. At present,...
Dr. Andrés Rodríguez -
Learn More
Bifurcations

ROUTE TRAIL: DKCRUSH vs. DKRUSH Culotte in Non-Left Main Bifurcation Lesions

Coronary bifurcation lesions represent a frequent technical challenge, making between 15% and 20% of cases. Though provisional...
Dr. Carlos Fava -
Learn More
Acute coronary syndromes

TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions

Supported by robust data, favorably compared against the transfemoral, the transradial approach has consolidated as the safest...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often...
Dr. Carlos Fava -
Learn More
Structural heart disease

TAVI and Aortic Regurgitation: Are All Valves the Same?

Aortic regurgitation (AR) accounts for 0.5- 2.2% of all cases of valve disease in individuals over 65...
Dr. Carlos Fava -
Learn More
Structural heart disease

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy